These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20373889)

  • 1. Surface characterization of poly(lactic acid)/everolimus and poly(ethylene vinyl alcohol)/everolimus stents.
    Wu M; Kleiner L; Tang FW; Hossainy S; Davies MC; Roberts CJ
    Drug Deliv; 2010 Aug; 17(6):376-84. PubMed ID: 20373889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoscale mechanical measurement determination of the glass transition temperature of poly(lactic acid)/everolimus coated stents in air and dissolution media.
    Wu M; Kleiner L; Tang FW; Hossainy S; Davies MC; Roberts CJ
    Eur J Pharm Sci; 2009 Mar; 36(4-5):493-501. PubMed ID: 19111614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of interfacial layer wettability and thickness on the coating morphology and sirolimus release for drug-eluting stent.
    Bedair TM; Yu SJ; Im SG; Park BJ; Joung YK; Han DK
    J Colloid Interface Sci; 2015 Dec; 460():189-99. PubMed ID: 26319336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials.
    Tanimoto S; Serruys PW; Thuesen L; Dudek D; de Bruyne B; Chevalier B; Ormiston JA
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):515-23. PubMed ID: 17503509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of Polymeric Prodrug Paclitaxel-Poly(lactic acid)-b-Polyisobutylene and Its Application in Coatings of a Drug Eluting Stent.
    Ren K; Zhang M; He J; Wu Y; Ni P
    ACS Appl Mater Interfaces; 2015 Jun; 7(21):11263-71. PubMed ID: 25955234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymeric stents: degradable but strong.
    Lemos PA
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):524. PubMed ID: 17896407
    [No Abstract]   [Full Text] [Related]  

  • 7. Modeling of degradation and drug release from a biodegradable stent coating.
    Prabhu S; Hossainy S
    J Biomed Mater Res A; 2007 Mar; 80(3):732-41. PubMed ID: 17167794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-in-human implantation of a fully bioabsorbable drug-eluting stent: the BVS poly-L-lactic acid everolimus-eluting coronary stent.
    Ormiston JA; Webster MW; Armstrong G
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):128-31. PubMed ID: 17139655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
    Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
    J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late stent recoil of the bioabsorbable everolimus-eluting coronary stent and its relationship with plaque morphology.
    Tanimoto S; Bruining N; van Domburg RT; Rotger D; Radeva P; Ligthart JM; Serruys PW
    J Am Coll Cardiol; 2008 Nov; 52(20):1616-20. PubMed ID: 18992650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(Lactic Acid) Hemodialysis Membranes with Poly(Lactic Acid)-block-Poly(2-Hydroxyethyl Methacrylate) Copolymer As Additive: Preparation, Characterization, and Performance.
    Zhu L; Liu F; Yu X; Xue L
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):17748-55. PubMed ID: 26222398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of mixed self-assembled monolayers for a potential use in everolimus eluting coronary stents.
    Mirmohseni A; Hosseini J; Shojaei M; Davaran S
    Colloids Surf B Biointerfaces; 2013 Dec; 112():330-6. PubMed ID: 24012664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of solvent on drug release and a spray-coated matrix of a sirolimus-eluting stent coated with poly(lactic-co-glycolic acid).
    Choi J; Jang BN; Park BJ; Joung YK; Han DK
    Langmuir; 2014 Aug; 30(33):10098-106. PubMed ID: 25090045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin-C delivery from CoCr alloy surfaces using polymer-free and polymer-based platforms for cardiovascular stent applications.
    Thiruppathi E; Mani G
    Langmuir; 2014 Jun; 30(21):6237-49. PubMed ID: 24832897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo changes to PLGA/sirolimus coating on drug eluting stents.
    Xi T; Gao R; Xu B; Chen L; Luo T; Liu J; Wei Y; Zhong S
    Biomaterials; 2010 Jul; 31(19):5151-8. PubMed ID: 20382420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring in vivo absorption of a drug-eluting bioabsorbable stent with intravascular ultrasound-derived parameters a feasibility study.
    Bruining N; de Winter S; Roelandt JR; Regar E; Heller I; van Domburg RT; Hamers R; Onuma Y; Dudek D; Webster MW; Thuesen L; Ormiston JA; Cheong WF; Miquel-Hebert K; Veldhof S; Serruys PW
    JACC Cardiovasc Interv; 2010 Apr; 3(4):449-56. PubMed ID: 20398874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrografting of a biodegradable layer as a primer adhesion coating onto a metallic stent: in vitro and in vivo evaluations.
    Vergnol G; Renard E; Haroun F; Guerin P; Seron A; Bureau C; Loirand G; Langlois V
    J Mater Sci Mater Med; 2013 Dec; 24(12):2729-39. PubMed ID: 23904056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pore networks and polymer rearrangement on a drug-eluting stent as revealed by correlated confocal Raman and atomic force microscopy.
    Biggs KB; Balss KM; Maryanoff CA
    Langmuir; 2012 May; 28(21):8238-43. PubMed ID: 22533814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent.
    Udipi K; Chen M; Cheng P; Jiang K; Judd D; Caceres A; Melder RJ; Wilcox JN
    J Biomed Mater Res A; 2008 Jun; 85(4):1064-71. PubMed ID: 17937416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer.
    Grube E; Sonoda S; Ikeno F; Honda Y; Kar S; Chan C; Gerckens U; Lansky AJ; Fitzgerald PJ
    Circulation; 2004 May; 109(18):2168-71. PubMed ID: 15123533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.